Cardiology Clinical Trials in Suffolk, VA
As of June 2026, 3 paid clinical trials are recruiting for Cardiology in Suffolk, Virginia. Cardiology trials investigate SGLT-2 inhibitors, myosin modulators, lipid-lowering therapies, anti-inflammatory agents, and device-based interventions across heart failure, hypertension, AFib, and coronary artery disease. Compensation typically covers time, travel, and study visits, and many studies also include study-related medical care at no cost.
Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: .
Filter results
3 clinical trials for Cardiology
·Clear filters·↓ Download CSVOCEAN(a)-PreEvent - Olpasiran Trials of Cardiovascular Events And LipoproteiN(a) Reduction to Prevent First Major Cardiovascular Events
A Phase III Study of AZD0780 on Major Adverse CV Events in Patients With a History of ASCVD Events or at High Risk for a First Event
About research studies in Suffolk
Suffolk has approximately 15 recruiting research studies across a wide range of therapeutic areas. Virginia hosts the University of Virginia Health System, VCU Health, and Inova Health System, running clinical trials across oncology, cardiology, and neuroscience.
Top Research Study Locations in Suffolk
Researchers run research studies in Suffolk, VA at 10 active sites. The clinics below currently host the largest number of recruiting studies — each name is followed by the conditions they focus on most.
| Site | Specializes in | Active trials |
|---|---|---|
| Velocity Clinical Research, Suffolk | COVID-19 SARS-CoV-2 Infection, Cortisol Excess, Influenza | 3 |
| Cancer Specialists of Tidewater-Suffolk | Previously Treated Non-Small Cell Lung Cancer, Stage III Colon Cancer | 2 |
| Akero Clinical Study Site | MASH With Fibrosis, NASH With Fibrosis | 1 |
| Bon Secours Health Center at Harbour View | Lung Non-Small Cell Carcinoma, Lung Non-Small Cell Squamous Carcinoma, Lung Non-Squamous Non-Small Cell Carcinoma | 1 |
| Centricity Research | Cardiovascular Disease | 1 |
| Centricity Research Suffolk Primary Care | Obesity or Overweight, Type 2 Diabetes Mellitus | 1 |
| Centricity Research VIR - DBA IACT Health Virginia Gastroenterology Institute Research | Crohn's Disease, Ulcerative Colitis | 1 |
| Clincial Research Site 18 | Non-healing Wound, Venous Insufficiency of Leg, Venous Leg Ulcer | 1 |
| Clinical Trial Site | High Cardiovascular Risk, High Risk Cardiovascular Disease, Hypertension | 1 |
| Velocity Clinical Research - Suffolk | Chronic Obstructive Pulmonary Disease | 1 |
Active & Upcoming Studies in Suffolk (2026)
Recruiting trials in Suffolk grouped by therapeutic area, drawn from ClinicalTrials.gov. Each bucket shows the most recent example studies.
Cancer & tumors (3 active studies)
- Colon Adjuvant Chemotherapy Based on Evaluation of Residual Disease · Phase 2, Phase 3 · NRG Oncology
- Testing the Addition of a Type of Drug Called Immunotherapy to the Usual Chemotherapy Treatment for Non-small Cell Lung Cancer, an ALCHEMIST Treatment Trial (Chemo-IO [ACCIO]) · Phase 3 · National Cancer Institute (NCI)
Diabetes & metabolic (3 active studies)
- A Clinical Study to Evaluate the Effects of Enicepatide (RO7795068) in Participants With Obesity or Overweight and Type 2 Diabetes · Phase 3 · Hoffmann-La Roche
- Trial Against INtractable Type 2 Diabetes (CAPTAIN-T2D) · Phase 2 · Sparrow Pharmaceuticals
Vaccines (2 active studies)
Cardiovascular (1 active study)
Common conditions studied in Suffolk
- Cardiovascular Disease (2 active studies). Recruiting Cardiovascular Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- COPD (Chronic Obstructive Pulmonary Disease) (1 active study). Chronic obstructive pulmonary disease trials investigate biologic therapies, triple-inhaler regimens, and anti-inflammatory approaches to reduce exacerbations.
- COVID-19 SARS-CoV-2 Infection (1 active study). COVID-19 research evaluates next-generation vaccines, antivirals, and therapies for long COVID.
- Chronic Obstructive Pulmonary Disease (1 active study). COPD research evaluates biologic therapies, triple-inhaler combinations, and new anti-inflammatory agents to reduce exacerbations.
- Cortisol Excess (1 active study). Recruiting Cortisol Excess studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
- Crohn's Disease (1 active study). Recruiting Crohn's Disease studies evaluate investigational treatments, diagnostics, and supportive care approaches to improve patient outcomes.
Leading research sponsors in Suffolk
- AstraZeneca
- Akero Therapeutics, Inc
- Alnylam Pharmaceuticals
- Amgen
- Hoffmann-La Roche
Local regulations and guidelines
Clinical trials in Virginia are governed by U.S. Food and Drug Administration (FDA) regulations, Office for Human Research Protections (OHRP) standards, and federal HIPAA privacy rules. Every study is reviewed by an Institutional Review Board (IRB) to protect participant safety and ensure informed consent. Virginia research additionally follows state public health department oversight and any applicable state privacy statutes.
Compensation & what to expect
- How payment typically works
- Compensation is most often provided through reloadable electronic study cards or direct deposit, paid out per completed visit rather than as a lump sum. Amounts vary by the time required, the number of visits, and the study's complexity — overnight stays and inpatient pharmacology studies generally pay more than short outpatient surveys. The exact amount is disclosed in writing during informed consent before any visit.
- Healthy volunteers
- Healthy participants aged 18 and older can earn compensation by joining vaccine, pharmacology, and biomarker studies in Suffolk. These trials check how a new drug or vaccine behaves in healthy bodies before later-phase testing. Many sites maintain a healthy-volunteer registry so you hear about new opportunities first.
- What's included beyond payment
- Most trials cover study-related medical care at no cost — physical exams, lab work, imaging, the investigational treatment itself, and follow-up visits with the research team. Insurance is not required to participate. Free check-ups and access to specialists are common reasons participants return for additional studies.
- Travel and time
- Many sponsors reimburse travel, parking, mileage, and lost wages for visit days. Long-running studies and trials that require frequent visits often raise stipends accordingly. Ask the study coordinator for the visit schedule and reimbursement policy before you commit.
- Asking about compensation
- Compensation is set per protocol and per site, so figures are not published in trial registries. The fastest way to confirm payment for a specific study is to contact the recruiting site listed on the study record. Coordinators are accustomed to this question and will quote the per-visit and total amounts up front.
How to find a clinical trial in Suffolk
Hipa.ai aggregates every recruiting study in Suffolk from ClinicalTrials.gov and refreshes the list daily. Use the filters above to narrow by condition, facility, age, phase, or healthy-volunteer eligibility, then click any study title to view full details — eligibility criteria, intervention, location, and sponsor contact information. To enroll, reach out to the central study contact listed on the study detail page; the research coordinator will walk you through the screening process.
Frequently asked questions
How many paid clinical trials are currently recruiting in Suffolk?
There are approximately 15 recruiting clinical trials in Suffolk, Virginia listed on ClinicalTrials.gov. The number changes weekly as new studies open and others close enrollment.
Do clinical trials in Suffolk pay participants?
Most recruiting trials in Suffolk compensate participants for their time, travel, and study visits. Compensation varies by sponsor, study phase, and visit requirements — the exact amount is disclosed by the study team during the informed consent process.
Who can participate in a clinical trial in Suffolk?
Eligibility depends on the specific study. Each trial defines its own inclusion criteria (age, diagnosis, medical history, prior treatments) and exclusion criteria. Both patients with specific conditions and healthy volunteers can qualify, depending on the study design.
What conditions are most commonly studied in Suffolk?
The most common conditions under active study in Suffolk include Cardiovascular Disease (2), COPD (Chronic Obstructive Pulmonary Disease) (1), COVID-19 SARS-CoV-2 Infection (1), Chronic Obstructive Pulmonary Disease (1), among many others. Browse the list above to explore every recruiting trial.
Are there clinical trials for healthy volunteers in Suffolk?
Yes. Healthy-volunteer studies — often early-phase pharmacology or vaccine trials — recruit in Suffolk on an ongoing basis. Use the "Healthy volunteers only" filter above to view trials that accept participants without the study's target condition.
How do I enroll in a clinical trial in Suffolk?
Click any study title above to see the full study record, including eligibility criteria, visit schedule, and the study team's contact information. Reach out to the central contact or recruiting site directly — they will guide you through screening and informed consent.
Where can I take part in paid clinical trials in Suffolk?
Recruiting research sites in Suffolk include Velocity Clinical Research, Suffolk, Cancer Specialists of Tidewater-Suffolk, Akero Clinical Study Site, among others. Each site lists its open studies and contact information on the study record above — call or email the site coordinator to ask about screening for a specific protocol.
What kinds of studies are recruiting in Suffolk right now?
The largest active categories in Suffolk are Cancer & tumors (3), Diabetes & metabolic (3), Vaccines (2). Use the filters above to narrow by therapeutic area, phase, age, or healthy-volunteer eligibility.